Riskpilot← Back to searchSign inGet full accessRanya Med AB
ABActiveOrg 5590520671Temporary employment agency activities and other human resource provisions · NACE 7820Est. 20163 employees
Revenue 2025
SEK 2M
-42% vs 2024
EBITDA margin
-34.0%
-332% vs 2024
Equity ratio
15.9%
Financial strength
Net profit 2025
SEK -545K
-318% vs 2024
| Revenue | SEK 2M | -42% |
| EBITDA | SEK -678K | -332% |
| Net profit | SEK -545K | -318% |
| Total assets | SEK 790K | -61% |
| Equity | SEK 125K | -80% |
| Employees | 3 | — |
Legal name
Ranya Med AB
Org number
5590520671
Legal form
Aktiebolag
NACE code
7820 · Temporary employment agency activities and other human resource provisions
Founded
22 februari 2016
Share capital
SEK 50 000
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva estetiska behandlingar i egen verksamhet samt utföra tjänster som allmänläkare och som öppenvårdsgynekolog inom primärvården.
Address
Email
sajdafa4@yahoo.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 543 | 1 897 | 3 400 | 3 419 | 1 994 |
| Staff expenses | — | — | −1 403 | −1 688 | −1 123 |
| EBITDA | 74 | 339 | 511 | 292 | −678 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 74 | 339 | 511 | 292 | −678 |
| Net financials | — | −9 | 15 | 27 | 0 |
| Profit before tax | 74 | 331 | 394 | 318 | −545 |
| Tax | −16 | −73 | −82 | −69 | — |
| Net profit | 58 | 258 | 312 | 250 | −545 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 474 | 906 | 1 933 | 2 046 | 790 |
| Equity | 470 | 869 | 362 | 611 | 125 |
| Long-term debt | 40 | 0 | 922 | −46 | 0 |
| Short-term debt | 44 | 37 | 516 | 1 348 | 665 |
| Total debt | 84 | 37 | 1 438 | 1 302 | 665 |
EBITDA margin
-34.0%
This company
15.8%
Market median
-315% vs market
20212025
Equity ratio
15.9%
This company
38.2%
Market median
-58% vs market
20212025
Return on equity
-435.1%
This company
18.4%
Market median
-2465% vs market
20212025
Net profit margin
-27.3%
This company
8.1%
Market median
-437% vs market
20212025
Asset turnover
2.52×
This company
1.12×
Market median
+125% vs market
20212025
Debt / equity
5.31×
This company
0.62×
Market median
-756% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
AK Chief Executive Officer | Chief Executive Officer | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
| Deputy Board Member | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ranya Med AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Atheer Kadum Mustafa Ramahi | Chief Executive Officer | 0 companies |
| Ranya Atheer Ramahi | Deputy Board Member | 0 companies |
| Sajda Farman Hajar | Board of Directors | 0 companies |
| Mustafa Atheer Ramahi | Deputy Board Member | 0 companies |